Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Meza

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
BMC Infectious Diseases|December 9, 2022
Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trialCarmen de la Rocha, Marco A Cid-López, Blanca I Venegas-López, et al.
Scientific Reports|April 19, 2018
Novel HLA class I associations with HIV-1 control in a unique genetically admixed populationHumberto Valenzuela-Ponce, Selma Alva-Hernández, Daniela Garrido-Rodríguez, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
BMC Infectious Diseases|December 9, 2022
Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trialCarmen de la Rocha, Marco A Cid-López, Blanca I Venegas-López, et al.
Scientific Reports|April 19, 2018
Novel HLA class I associations with HIV-1 control in a unique genetically admixed populationHumberto Valenzuela-Ponce, Selma Alva-Hernández, Daniela Garrido-Rodríguez, et al.
Pageof 13